Noninvasive diagnostic techniques for coronary disease in women

Clinical Cardiology

Volumn 35, Issue 3, 2012, Pages 149-155

  Vavas, Eleni ^a   Hong, Susie N ^b   Rosen, Stacey E ^a   Mieres, Jennifer H ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; MORTALITY; MYOCARDIAL PERFUSION IMAGING; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; SURVIVAL;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY DISEASE; DIAGNOSTIC TECHNIQUES AND PROCEDURES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FUNCTION TESTS; HUMANS; INCIDENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL RATE; UNITED STATES; WOMEN'S HEALTH;

EID: 84858012280     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21953     Document Type: Review

References (55)

1. Bairey Merz CN, Shaw LJ, et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006; 47: S21-S29.
2. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356: 2388-2398. (Pubitemid 46883773)
3. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol. 2007; 49: 1230-1250. (Pubitemid 46400344)
4. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation. 2011; 123: 1243-1262.
5. American Heart Association. Heart Disease and Stroke Statistics:2004 Update. Dallas, TX: American Heart Association; 2003.
6. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004; 109: 672-693. (Pubitemid 38198877)
7. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006; 47: S4-S20.
8. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010; 121: e46-e215.
9. Blomkalns AL, Chen AY, Hochman JS, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005; 45: 832-837. (Pubitemid 40347306)
10. Vaccarino V., Ischemic heart disease in women: many questions, few facts. Circ Cardiovasc Qual Outcomes. 2010; 3: 111-115.
11. Murphy SL., Deaths: final data for 1998. Natl Vital Stat Rep. 2000; 48: 1-105.
12. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002; 40: 1531-1540. (Pubitemid 35192881)
13. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005; 111: 682-696. (Pubitemid 40216498)
14. Phillips LM, Mieres JH., Noninvasive assessment of coronary artery disease in women: What's next? Curr Cardiol Rep. 2010; 12: 147-154.
15. Shaw LJ, Bugiardini R, Merz CN., Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009; 54: 1561-1575.
16. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009; 169: 843-850.
17. Kohli P, Gulati M., Exercise stress testing in women: going back to the basics. Circulation. 2010; 122: 2570-2580.
18. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999; 83: 660-666. (Pubitemid 29116372)
19. Alexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998; 32: 1657-1664. (Pubitemid 28545205)
20. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003; 42: 954-970. (Pubitemid 37069224)
21. Shaw LJ, Vasey C, Sawada S, et al. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005; 26: 447-456. (Pubitemid 40314760)
22. Arruda-Olson AM, Juracan EM, Mahoney DW, et al. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol. 2002; 39: 625-631. (Pubitemid 34158158)
23. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation. 2003; 108: 1554-1559. (Pubitemid 37187780)
24. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index). Am J Cardiol. 1989; 64: 651-654. (Pubitemid 19230238)
25. Shaw LJ, Olson MB, Kip K, et al. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol. 2006; 47: S36-S43.
26. Shaw LJ, Mieres JH, Hendel RH, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the What Is the Optimal Method for Ischemia Evaluation in Women (WOMEN) Trial. Circulation. 2011; 124: 1239-1249.
27. Williams MJ, Marwick TH, O'Gorman D, et al. Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women. Am J Cardiol. 1994; 74: 435-438. (Pubitemid 24269959)
28. Metz LD, Beattie M, Hom R, et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007; 49: 227-237. (Pubitemid 46054393)
29. Mieres JH, Shaw LJ, Hendel RC, et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease-the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol. 2003; 10: 95-101. (Pubitemid 36335859)
30. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003; 108: 1404-1418. (Pubitemid 37174421)
31. Hansen CL, Crabbe D, Rubin S., Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol. 1996; 28: 1214-1219. (Pubitemid 26376997)
32. Mieres JH, Makaryus AN, Cacciabaudo JM, et al. Value of electrocardiographically gated single-photon emission computed tomographic myocardial perfusion scintigraphy in a cohort of symptomatic postmenopausal women. Am J Cardiol. 2007; 99: 1096-1099. (Pubitemid 46560464)
33. Santana-Boado C, Candell-Riera J, Castell-Conesa J, et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med. 1998; 39: 751-755. (Pubitemid 28216717)
34. Bokhari S, Shahzad A, Bergmann SR., Superiority of exercise myocardial perfusion imaging compared with the exercise ECG in the diagnosis of coronary artery disease. Coron Artery Dis. 2008; 19: 399-404.
35. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006; 114: 1761-1791. (Pubitemid 44607126)
36. U.S. Preventive Services, Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med. 2004; 140: 569-572.
37. Raggi P, Shaw LJ, Berman DS, et al. Gender-based differences in the prognostic value of coronary calcification. J Womens Health (Larchmt). 2004; 13: 273-283. (Pubitemid 38660524)
38. Heller GV, Calnon D, Dorbala S., Recent advances in cardiac PET and PET/CT myocardial perfusion imaging. J Nucl Cardiol. 2009; 16: 962-969.
39. Di Carli MF, Hachamovitch R., New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007; 115: 1464-1480. (Pubitemid 46648384)
40. Dorbala S, Giugliano RP, Logsetty G, et al. Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I levels and atypical clinical presentation. J Nucl Cardiol. 2007; 14: 53-58. (Pubitemid 46187492)
41. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007; 49: 378-402.
42. Budoff MJ, Dowe D, Jollis JG, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008; 52: 1724-1732.
43. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008; 359: 2324-2336.
44. Pundziute G, Schuijf JD, Jukema JW, et al. Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart. 2008; 94: 48-52.
45. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002; 346: 1948-1953. (Pubitemid 34651354)
46. Wallace EL, Morgan TM, Walsh TF, et al. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging. 2009; 2: 299-307.
47. Gebker R, Jahnke C, Hucko T, et al. Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease in women. Heart. 2010; 96: 616-620.
48. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001; 103: 2230-2235. (Pubitemid 32433710)
49. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000; 101: 1379-1383. (Pubitemid 30169858)
50. Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol. 2006; 47: 1427-1432.
51. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004; 110: 835-842. (Pubitemid 39096012)
52. Rieber J, Huber A, Erhard I, et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J. 2006; 27: 1465-1471. (Pubitemid 43998081)
53. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation. 2007; 115: 1769-1776. (Pubitemid 46648614)
54. Pennell DJ., Cardiovascular magnetic resonance. Circulation. 2010; 121: 692-705.
55. Arai AE., The cardiac magnetic resonance (CMR) approach to assessing myocardial viability. J Nucl Cardiol. 2011; 18: 1095-1102.